Skip to content

The effectiveness of breastmilk booster supplementation to enhance the quantity and quality of breastmilk production

The effectiveness of breastmilk booster supplementation to enhance the quantity and quality of breastmilk production

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20241122003
Enrollment
80
Registered
2024-11-22
Start date
2024-11-04
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary health condition studied: breastmilk production in lactating mothers. This study investigates the effectiveness of breastmilk booster supplementation to enhance both the quantity and quality of breastmilk. breastfeeding breastmilk booster breastmilk production

Interventions

The intervention group, which received a daily intake of a commercial breastmilk booster supplement containing active ingredients such as Moringa oleifera (kelor leaves), Channa striata (snakehead fis
Breastmilk Booster Group,Placebo Group

Sponsors

Center For Health and Nutrition Education, Counseling and Empowerment Research Group, Public Health Faculty, Universitas Airlangga
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Healthy lactating mother with an infant aged 0-5 months at the time of recruitment. 2. Currently providing exclusive breastfeeding. 3. Willing to participate in the study from baseline to endline. 4. Has not consumed any specific supplements intended to boost breast milk production within three weeks prior to the start of the study. 5. Agrees not to consume any other product, except those provided by the research team, to boost breast milk production during the study.

Exclusion criteria

Exclusion criteria: 1. Developing health conditions during the study period that could interfere with breastfeeding or lactation (e.g., infections, mastitis, or hormonal imbalances). 2. Infant health issues emerging during the study that affect feeding (e.g., illness or difficulty latching). 3. Starting any medications that could influence milk production after study enrollment. 4. Introduction of non-research-approved supplements or products meant to boost breast milk production during the study. 5. Non-compliance with study protocols, such as failure to follow exclusive breastfeeding or supplement guidelines. 6. Unexpected life changes that prevent the mother from continuing in the study (e.g., relocation or return to work that disrupts breastfeeding).

Design outcomes

Primary

MeasureTime frame
Breastmilk Quantity three times, three days Volume (mL),Breastmilk Energy Content three times, three days Kkal,Breastmilk Carbohydrate Content three times, three days gr,Breastmilk Protein Content three times, three days gr,Breastmilk Calcium Content three times, three days mg,Breastmilk Omega 3 Content three times, three days mg,Breastmilk DHA Content three times, three days mg,Breastmilk EPA Content three times, three days mg

Secondary

MeasureTime frame
Mother's Energy Intake three times, three days 24 hr food recall (kkal),Mother's Carbohydrate Intake three times, three days 24 hr food recall (gr),Mother's Protein Intake three times, three days 24 hr food recall (gr),Mother's Calcium Intake three times, three days 24 hr food recall (gr)

Countries

Indonesia

Contacts

Public ContactTrias Mahmudiono

Universitas Airlangga

trias-m@fkm.unair.ac.id081554219427

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026